| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | W Burleson Daviss | |
| P2860 | cites work | Study 329 | Q20746326 |
| Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder | Q22242745 | ||
| Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness | Q28204939 | ||
| Comorbidity | Q33548186 | ||
| Attention-deficit/hyperactivity disorder and comorbidity | Q33778177 | ||
| The stimulants revisited. | Q34005063 | ||
| Does pharmacotherapy for attention-deficit/hyperactivity disorder predict risk of later major depression? | Q34112070 | ||
| The use of antidepressants to treat depression in children and adolescents | Q34257369 | ||
| Mania-Like Symptoms Suggestive of Childhood-Onset Bipolar Disorder in Clinically Referred Children | Q34303286 | ||
| Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial | Q34341755 | ||
| Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. | Q34444579 | ||
| The genetic aetiology of childhood depression: a review | Q34521137 | ||
| The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder | Q34529904 | ||
| Criterion validity of the Mood and Feelings Questionnaire for depressive episodes in clinic and non-clinic subjects | Q34560170 | ||
| Ten-year review of rating scales. II: Scales for internalizing disorders | Q34671015 | ||
| Practice parameter for the assessment and treatment of children and adolescents with depressive disorders | Q34720078 | ||
| Childhood and adolescent depression: a review of the past 10 years. Part I. | Q34736609 | ||
| Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview | Q34749777 | ||
| Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder | Q84288971 | ||
| Treatment for Adolescents with Depression Study (TADS): safety results | Q35773690 | ||
| Attention deficit hyperactivity disorder and suicide: a review of possible associations | Q35936928 | ||
| Differentiating major depressive disorder in youths with attention deficit hyperactivity disorder | Q36116958 | ||
| The genetics of attention deficit hyperactivity disorder | Q36294706 | ||
| Depressive disorders in childhood and adolescence: an overview: epidemiology, clinical manifestation and risk factors | Q36585489 | ||
| Cognitive behavioral therapy for depression in youth. | Q36585501 | ||
| Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). | Q36669012 | ||
| Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder | Q36827079 | ||
| Academic pathways between attention problems and depressive symptoms among urban African American children | Q36908448 | ||
| Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder | Q39227495 | ||
| Developmental transitions among affective and behavioral disorders in adolescent boys | Q40379443 | ||
| Attention deficit disorder: a review of the past 10 years | Q41074795 | ||
| Do attention deficit hyperactivity disorder and major depression share familial risk factors? | Q41599890 | ||
| Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression | Q43565910 | ||
| Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder | Q43990359 | ||
| Comorbidity of unipolar depression: II. Comorbidity with other mental disorders in adolescents and adults | Q44049974 | ||
| Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial | Q44168453 | ||
| Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood | Q44693587 | ||
| Enduring behavioral effects of early exposure to methylphenidate in rats | Q44693590 | ||
| Depression in attention deficit hyperactivity disorder (ADHD) children: "true" depression or demoralization? | Q44886741 | ||
| New insights into the comorbidity between ADHD and major depression in adolescent and young adult females | Q45740288 | ||
| Children with ADHD and depression: a multisource, multimethod assessment of clinical, social, and academic functioning | Q48477499 | ||
| Impact of comorbid attention deficit disorder on the direct medical costs of treating adults with depression in managed care. | Q50799719 | ||
| A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. | Q50924850 | ||
| Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. | Q51899719 | ||
| Co-occurrence of conduct disorder and depression in a clinic-based sample of boys with ADHD. | Q51935758 | ||
| A feasibility study of the childhood depression medication algorithm: the Texas Children's Medication Algorithm Project (CMAP). | Q51941426 | ||
| Impact of comorbidity on a cognitive-behavioral group treatment for adolescent depression. | Q51965435 | ||
| Attention deficit-hyperactivity disorder, depression, and self- and other-assessments of social competence: a developmental study. | Q52003514 | ||
| Childhood-onset dysthymic disorder. Clinical features and prospective naturalistic outcome. | Q52026388 | ||
| Comorbidity of unipolar depression: I. Major depression with dysthymia. | Q52050439 | ||
| Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. | Q52918729 | ||
| Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. | Q53980986 | ||
| Attention-Deficit/Hyperactivity Disordered and Control Boys' Responses to Social Success and Failure | Q57934285 | ||
| Attention deficit hyperactivity disorder in childhood among adults with major depression | Q59675006 | ||
| Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation | Q70392247 | ||
| A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response | Q70550342 | ||
| Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms | Q70798795 | ||
| Attention-deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity? | Q71393232 | ||
| Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children | Q72000594 | ||
| Psychiatric comorbidity among referred juveniles with major depression: fact or artifact? | Q72298542 | ||
| The self-perceptions and attributions of attention deficit hyperactivity disordered and nonreferred boys | Q72842346 | ||
| Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder | Q73256562 | ||
| Parent and child contributions to diagnosis of mental disorder: are both informants always necessary? | Q73268507 | ||
| Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials | Q73684922 | ||
| Potential cognitive, parenting, and developmental mediators of the relationship between ADHD and depression | Q82899687 | ||
| P433 | issue | 6 | |
| P921 | main subject | attention deficit hyperactivity disorder | Q181923 |
| P304 | page(s) | 565-571 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Journal of Child and Adolescent Psychopharmacology | Q15756086 |
| P1476 | title | A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment | |
| P478 | volume | 18 |
| Q36114644 | A 4-Year Follow-Up Study of Attention-Deficit Hyperactivity Symptoms, Comorbidities, and Psychostimulant Use in a Brazilian Sample of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder |
| Q42697087 | A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders |
| Q22061957 | A Developmental Psychopathology Perspective on ADHD and Comorbid Conditions: The Role of Emotion Regulation |
| Q44888879 | A comparative analysis of health-related quality of life and family impact between children with ADHD treated in a general pediatric clinic and a psychiatric clinic utilizing the PedsQL. |
| Q34332823 | A multimodal MRI study of the hippocampus in medication-naive children with ADHD: what connects ADHD and depression? |
| Q33820624 | A novel group therapy for children with ADHD and severe mood dysregulation. |
| Q99630774 | ADHD and Depression: the Role of Poor Frustration Tolerance |
| Q63684302 | ADHD and depressive symptoms in adolescents: the role of community violence exposure |
| Q47993344 | Adolescent depression and the treatment gap. |
| Q44093861 | Association of ADHD and Executive Functioning With Childhood Depression |
| Q33767465 | Associations among ADHD, Abnormal Eating and Overweight in a non-clinical sample of Asian children |
| Q89950926 | Associations between ADHD and emotional problems from childhood to young adulthood: a longitudinal genetically sensitive study |
| Q44799645 | Associations of lifetime depression with trauma exposure, other environmental adversities, and impairment in adolescents with ADHD. |
| Q33803515 | Attention-deficit/hyperactivity disorder (ADHD) and high risk behaviors |
| Q33900589 | Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research |
| Q48251965 | Attention-deficit/hyperactivity disorder and social skills in youth: a moderated mediation model of emotion dysregulation and depression. |
| Q37210535 | Attention-deficit/hyperactivity disorder in adolescence predicts onset of major depressive disorder through early adulthood |
| Q34384578 | Atypical default network connectivity in youth with attention-deficit/hyperactivity disorder |
| Q37624913 | Behavioral impairments in rats with chronic epilepsy suggest comorbidity between epilepsy and attention deficit/hyperactivity disorder |
| Q50421813 | Bright light therapy versus physical exercise to prevent co-morbid depression and obesity in adolescents and young adults with attention-deficit / hyperactivity disorder: study protocol for a randomized controlled trial |
| Q36717211 | Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study |
| Q92599662 | Childhood neurodevelopmental difficulties and risk of adolescent depression: the role of irritability |
| Q35187232 | Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. |
| Q38160389 | Co-occurring aggressive and depressive symptoms as related to overestimations of competence in children with attention-deficit/hyperactivity disorder |
| Q33620351 | Comorbid Depressive Disorders in ADHD: The Role of ADHD Severity, Subtypes and Familial Psychiatric Disorders. |
| Q47728879 | Comorbidity prevalence and treatment outcome in children and adolescents with ADHD. |
| Q38689665 | Critical exploration of co-occurring Attention-Deficit/Hyperactivity Disorder, mood disorder and Substance Use Disorder |
| Q48983593 | Depression and Anxiety Among Transitioning Adolescents and College Students With ADHD, Dyslexia, or Comorbid ADHD/Dyslexia |
| Q50346291 | Depression symptoms in boys with autism spectrum disorder and comparison samples |
| Q33662918 | Differences in Resting-state Quantitative Electroencephalography Patterns in Attention Deficit/Hyperactivity Disorder with or without Comorbid Symptoms |
| Q48618094 | Distinct neuropsychological profiles within ADHD: a latent class analysis of cognitive control, reward sensitivity and timing |
| Q35761836 | Does comorbid depression predict subsequent adverse life events in youth with attention-deficit/hyperactivity disorders? |
| Q48190973 | Effects of lisdexamfetamine alone and in combination with s-citalopram on acetylcholine and histamine efflux in the rat pre-frontal cortex and ventral hippocampus |
| Q42112342 | Effects of psychotropic drugs on second messenger signaling and preference for nicotine in juvenile male mice |
| Q36664940 | Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy |
| Q30577968 | Elevating hope among children with Attention deficit and hyperactivity disorder through virtual reality |
| Q34803697 | Emotion dysregulation in attention deficit hyperactivity disorder |
| Q34394710 | Emotion regulation mediates the association between ADHD and depressive symptoms in a community sample of youth |
| Q48800931 | Emotion regulation mediates the relationship between ADHD and depressive symptoms in youth |
| Q42316089 | Evaluation of the Relationship between Brain-Derived Neurotropic Factor Levels and the Stroop Interference Effect in Children with Attention-Deficit Hyperactivity Disorder |
| Q33829721 | Examination of the Comorbidity of Mental Illness and Somatic Conditions in Hospitalized Children in the United States Using the Kids' Inpatient Database, 2009. |
| Q61852600 | Factors associated with depression and anxiety in children with intellectual disabilities |
| Q48043702 | Family and Maternal Characteristics of Children With Co-Occurring ADHD and Depression |
| Q30251626 | Functional consequences of attention-deficit hyperactivity disorder on children and their families |
| Q40230678 | Genetic and environmental contributions to the association between ADHD and affective problems in early childhood-A Swedish population-based twin study |
| Q47603006 | Impact of depressive/anxiety symptoms on the quality of life of adolescents with ADHD: a community-based 1-year prospective follow-up study |
| Q90212333 | Impact of sleep restriction on affective functioning in adolescents with attention-deficit/hyperactivity disorder |
| Q37130105 | Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression |
| Q37933510 | Inattention and hyperactivity and the achievement gap among urban minority youth |
| Q92136041 | Irritability in ADHD: association with later depression symptoms |
| Q37662734 | Is there a difference between child self-ratings and parent proxy-ratings of the quality of life of children with a diagnosis of attention-deficit hyperactivity disorder (ADHD)? A systematic review of the literature |
| Q35113807 | Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood |
| Q45023098 | Longitudinal Evaluation of the Cognitive-Behavioral Model of ADHD in a Sample of College Students With ADHD. |
| Q88525131 | Longitudinal Evaluation of the Role of Academic and Social Impairment and Parent-Adolescent Conflict in the Development of Depression in Adolescents with ADHD |
| Q39844901 | Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study |
| Q38980262 | Neural substrates of trait impulsivity, anhedonia, and irritability: Mechanisms of heterotypic comorbidity between externalizing disorders and unipolar depression |
| Q27343175 | Neurodevelopmental disruption of cortico-striatal function caused by degeneration of habenula neurons |
| Q47955272 | Neutral face distractors differentiate performance between depressed and healthy adolescents during an emotional working memory task |
| Q34726302 | Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007 |
| Q41495600 | Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients |
| Q44998777 | Physical Activity, Affect, and Cognition in Children With Symptoms of ADHD. |
| Q30469931 | Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure |
| Q33742332 | Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study |
| Q57192906 | Preschool Executive Function Predicts Childhood Resting-State Functional Connectivity and Attention-Deficit/Hyperactivity Disorder and Depression |
| Q47244033 | Psychometric Validation of the Revised Child Anxiety and Depression Scales-Parent Version (RCADS-P) in Children Evaluated for ADHD. |
| Q47424343 | Psychopathological, temperamental, and characteristic factors in adults with remaining childhood attention-deficit hyperactivity symptoms |
| Q36877283 | Psychotropic medication treatment of adolescents: results from the National Comorbidity Survey-Adolescent Supplement |
| Q46221314 | Risk factors for incident major depressive disorder in children and adolescents with attention-deficit/hyperactivity disorder. |
| Q48182741 | Sleep-related factors: associations with poor attention and depressive symptoms. |
| Q36373583 | Social and emotional difficulties in children with ADHD and the impact on school attendance and healthcare utilization |
| Q38973704 | Structural and Functional Abnormalities in Children with Attention-Deficit/Hyperactivity Disorder: A Focus on Subgenual Anterior Cingulate Cortex |
| Q47972742 | Suicidal behaviors in adolescents with ADHD: associations with depressive and other comorbidity, parent-child conflict, trauma exposure, and impairment. |
| Q92730403 | The Revised Child Anxiety and Depression Scales (RCADS): Psychometric Evaluation in Children Evaluated for ADHD |
| Q37790406 | The challenge of providing child health care in the Indigenous population of New Zealand |
| Q34014855 | The effects of temporally secondary co-morbid mental disorders on the associations of DSM-IV ADHD with adverse outcomes in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). |
| Q33620338 | The impact of depressive symptoms in adults with ADHD symptoms on family function and ADHD symptoms of their children |
| Q44200397 | The relationships between ADHD and social functioning and participation in older adults in a population-based study |
| Q38570190 | The relevance of neuropsychiatric symptoms and cognitive problems in new-onset epilepsy - Current knowledge and understanding |
| Q37682858 | Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan |
| Q38184948 | Use of SSRIs among Danish children: a nationwide study |
Search more.